INDIANAPOLIS, Ind., July 24, 2014 — BioCrossroads and AlpInvest Partners today announced their speaker line up for their eleventh annual Indiana Life Sciences Summit on Wednesday, October 15, 2014. Leaders from Cook Medical, Roche Diagnostics, TransCelerate BioPharma, Flexion Therapeutics, the State Science and Technology Institute, among others, will be providing their perspectives on topics relevant to Indiana’s life sciences industry as well as global trends.
Panel topics and speakers include:
Exploring New Avenues to Accelerate Research
- Debra Lappin, President, Council for American Medical Innovation and Principal, Faegre Baker Daniels Consulting
- Michael D. Clayman, M.D., CEO, Flexion Therapeutics
- Annalisa Jenkins, M.D., Chair of the Board, TransCelerate Biopharma
- Jack Philips, President and CEO, Roche Diagnostics
- Pete Yonkman, President, Cook Medical
Indiana Biosciences Research Institute’s Approach to Quicker Commercialization
- Gerry Dick, Host, Inside Indiana Business and Founder, Grow Indiana
- David Broecker, Interim Chief Operating Officer, Indiana Biosciences Research Institute
- Andrew Dahlem, D.V.M. (h.c.), Ph.D., Vice President, LRL Operations/LRL Europe, Eli Lilly and Company
- Jay Hess, M.D., Ph.D., M.H.S.A., Dean, Indiana University School of Medicine; Vice President for University Clinical Affairs, Indiana University
- Luke Kenley, Senator, Indiana State Senate
The Need for Capital and its Impact on Innovation and Research
- Nadim Barakat, Managing Director, Carlyle Group
- Mark Skinner, Vice President of the State Science & Technology Institute
- Derek Small, Co-Founder and Executive Chairman, Assembly Pharmaceuticals
The Summit will be at the JW Marriott, downtown Indianapolis. The networking reception hosted by Eli Lilly and Company and Cook Medical will be from 6:00 p.m. to 8:00 p.m. on Tues., Oct. 14. Winners of the New Venture Competition will also be announced that evening. Sponsors of the conference include Faegre Baker Daniels, Roche Diagnostics, Miles Printing, Indiana University, Indiana Economic Development Corporation, Bloomberg Government, and the Indiana Biosciences Research Institute.
BioCrossroads (www.biocrossroads.com) advances Indiana’s signature strengths in the life sciences by connecting with corporate, academic and philanthropic partners; facilitating investments in promising start ups and building new enterprises; and educating through conferences, reports and market development knowledge. The initiative supports the region’s existing research and corporate strengths while encouraging new business development and has formed several new nonprofit organizations, including Indiana Health Information Exchange, Fairbanks Institute for Healthy Communities, BioCrossroadsLINX, OrthoWorx, and Datalys Center.